AzTrials
AzTrials

FibromyalgiaNCT06157866

Cognitive Training to Enhance Brain Concordance During Acupuncture

A study testing Electroacupuncture, Cognitive Training and Education Training in people with Fibromyalgia, run by Spaulding Rehabilitation Hospital at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will evaluate the impact of a novel non-pharmacological multimodal therapy, a type of approach known to improve pain outcomes and recommended by the Institute of Medicine report for chronic pain management. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Fibromyalgia
What is being tested?
Electroacupuncture, Cognitive Training and Education Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
3 sitesUnited States
Study dates
16 Feb 2024to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Meet traditional American College of Rheumatology (ACR) criteria for FM as well as the more recent Wolfe et al 2011 criteria
  • Are on stable doses of medication for 30 days prior to entering the study and agree not to change medications or dosages during the trial
  • Ability to fully understand and consent to study procedures
  • Baseline pain intensity of at least 4/10
  • Pain duration of at least 6 months

Who cannot join

  • Any longer period of work experience involving pain treatment, pain rehabilitation etc.
  • Presence of any illness that is judged to interfere with the trial. For example: psychiatric disorder according to the DSM-IV manual
  • Presence of any contraindications to fMRI scanning. For example: cardiac pacemaker, metal implants, fear of closed spaces, pregnancy.
  • History of significant head injury
  • Inability to respond accurately to the pain-relieving intervention in the behavioral part of the experiment, indicating a lack of response to the expectancy manipulation. If the healthy volunteer or clinician is not a responder to the behavioral expectancy induction he or she will be excluded.
  • Unwillingness to receive brief experimental pain.
Show all 21Show fewer
  • Leg pain or health issues that may interfere with the study procedures.
  • Comorbid acute pain condition
  • Comorbid chronic pain condition that is rated by the subject as more painful than fibromyalgia
  • Current use of opioid analgesics
  • Concurrent inflammatory or autoimmune disease
  • Documented peripheral neuropathy
  • Pregnant
  • Any psychiatric disorder involving a history of psychosis (e. g schizophrenia, bipolar disorder, severe personality disorders)
  • History of anxiety disorders or significant anxiety symptoms interfering with fMRI procedures (e.g., panic)
  • Psychiatric hospitalization in the past 6 months
  • Unwillingness to withhold from consuming marijuana 12 hours prior to scans
  • Unwillingness to withhold from consuming nicotine 4 hours prior to scans
  • Any impairment, activity or situation that in the judgment of the Study Coordinator or Principal Investigator would prevent satisfactory completion of the study protocol.
  • Is an actual clinical patient of the clinician subject
  • Recent history of formal meditation-based training

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Seneca Ellis contact

617-952-6484

sellis11@mgb.org

Arvina Grahl, PhD contact

agrahl@mgh.harvard.edu

United States3 sites, 3 recruiting
  • Massachusetts General Hospital

    Charlestown, Massachusetts, 02129

    Seneca Ellis, 617-952-6484, sellis11@mgb.org

    Lara Gardiner, 617-952-6483, lgardiner1@mgb.org

    Recruiting
  • Spaulding Rehabilitation Hospital

    Charlestown, Massachusetts, 02129

    Seneca Ellis, 617-952-6484, sellis11@mgb.org

    Lara Gardiner, 617-952-6483, lgardiner1@mgb.org

    Recruiting
  • Brigham and Women's Hospital

    Chestnut Hill, Massachusetts, 02467

    Seneca Ellis, 617-952-6484, sellis11@mgb.org

    Lara Gardiner, 617-952-6483, lgardiner1@mgb.org

    Recruiting

Other trials in United States

About this study

Official title: Cognitive Training to Enhance Brain-to-brain Concordance During Acupuncture

This study will evaluate the impact of a novel non-pharmacological multimodal therapy, a type of approach known to improve pain outcomes and recommended by the Institute of Medicine report for chronic pain management. This study design will also allow the investigators to evaluate a neural model supporting therapeutic alliance for pain outcomes for fibromyalgia.

Read the detailed description

The patient-clinician interaction is central to most therapies and is supported by key interpersonal mechanisms of action such as clinician empathy, therapeutic alliance, and trust. However, the neural underpinnings of this effect are mostly unknown. The investigators' recently published study applied functional MRI (fMRI) hyperscanning (i.e. simultaneously neuroimaging chronic pain patients and clinicians in synchronized MRI scanners) demonstrated that brain-to-brain concordance in the temporoparietal junction (TPJ) is up-regulated following a clinical interaction and associated with patient analgesia. Fibromyalgia is a chronic pain disorder in great need of novel therapies. This study will evaluate the impact of a novel multimodal therapy, a type of approach known to improve pain outcomes and recommended by the Institute of Medicine report for chronic pain management. The study design will also allow the investigators to evaluate a neural model supporting therapeutic alliance for pain outcomes for fibromyalgia wherein training and acupuncture will synergistically target a critical therapeutic pathway - i.e., patient-provider alliance, instantiated by TPJ concordance.

Conditions
Fibromyalgia
Being tested
Electroacupuncture, Cognitive Training, Education Training
Keywords
hyperscan fmri, hyperscan EEG, acupuncture, fibromyalgia, chronic pain
Medical subject headings
Fibromyalgia, Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ElectroacupunctureOther

    During the treatment sessions the acupuncturist will insert needles in several locations aimed to reduce the patient's fibromyalgia pain. A low-amplitude, sub-sensory electrical current will be activated by the acupuncturist.

  • Cognitive TrainingBehavioural

    Cognitive training with a pain specialist.

  • Education TrainingBehavioural

    Education training with a pain specialist.

Study groups in NCT06157866
Study groupRoleWhat they receive
Cognitive TrainingExperimentalParticipants will meet with a pain specialist who will conduct a specific form of cognitive training targeting fibromyalgia.
Receives: Other: Electroacupuncture; Behavioral: Cognitive Training
Education TrainingActive comparatorParticipants will meet with a pain specialist to receive education training related to fibromyalgia.
Receives: Other: Electroacupuncture; Behavioral: Education Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brain Imaging-fMRI

    Hyperscan fMRI assessing brain-to-brain concordance between the patient and the clinician.

    Measured: Up to 6 months

Secondary outcomes (1)
  1. Brain Imaging-EEG

    Hyperscan EEG assessing brain-to-brain concordance between the patient and the clinician.

    Measured: Up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Dec 2023
  2. Study start16 Feb 2024
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06157866
Sponsor's protocol ID
2023P003155
Status last verified
Oct 2025
First submitted
5 Nov 2023
Last updated
24 Oct 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Per NIH guidelines

Publications

  • Yamin JB, Grahl A, Anzolin A, Doan TDN, Ellis S, Gardiner L, Hewardt I, Lee SA, Lee J, Kelley JM, Kaptchuk T, Napadow V, Edwards RR. Mentalizing & InteRpersonal Recognition of Others' Relational States (MIRROR): a patient-directed intervention for navigating clinical encounters in chronic pain. Pain Manag. 2026 Sep 28:1-14. doi: 10.1080/17581869.2026.2740677. Online ahead of print.

    PubMed 42803703

Questions about this trial

What is this clinical trial studying?

A study testing Electroacupuncture, Cognitive Training and Education Training in people with Fibromyalgia, run by Spaulding Rehabilitation Hospital at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 21 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Seneca Ellis (617-952-6484, sellis11@mgb.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brain Imaging-fMRI (time frame: Up to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06157866, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in